Virtual Medicinal Product (VMP) - Lanreotide 30mg powder and solvent for suspension for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Lanreotide 30mg powder and solvent for suspension for injection vials Start Date 04-06-2004 End Date
Previous Name Previous Name Lanreotide 30mg injection vials and diluent Start Date 26-03-2003 End Date 03-06-2004
Abbreviated Name Abbreviated Name Lanreotide 30mg inj vials Start Date 01-05-2009
Previous Abbreviated Name Lanreotide 30mg pdr & solv for susp for inj vials Previous Start Date 09-09-2004 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intramuscular
Form
Powder and solvent for suspension for injection
Ontology Form/Route
suspensioninjection.intramuscular
Non-availability Indicator
Actual Products not Available
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
H01CB03
BNF Start Date End Date
Current BNF 08030403 Start Date 04-04-2022 End Date
Previous BNF 08030403 Start Date 27-06-2005 End Date 03-04-2022
Previous BNF 08030402 Start Date 14-02-2005 End Date 26-06-2005
SNOMED Codes
Code Start Date End Date
36037811000001100 29-10-2018
327380000 17-10-2012 28-10-2018
4177711000001106 26-03-2003 16-10-2012

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Lanreotide acetate Based on Base Substance Lanreotide 30 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial